Comparison of pulsed actinomycin D versus 5-day methotrexate for the treatment of low-risk gestational trophoblastic disease

International Journal of Gynecology and Obstetrics

Volumn 116, Issue 1, 2012, Pages 39-42

  Mousavi, Azamsadat ^a   Cheraghi, Fatemeh ^a   Yarandi, Fariba ^b   Gilani, Mitra Modaress ^a   Shojaei, Hadi ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Actinomycin D; Low risk gestational trophoblastic disease; Methotrexate

Indexed keywords

DACTINOMYCIN; METHOTREXATE;

ADULT; ALOPECIA; ANOREXIA; ARTICLE; CHEMOTHERAPY; CONSTIPATION; DIARRHEA; DRUG EFFICACY; FATIGUE; FEMALE; HEMOPTYSIS; HUMAN; MAJOR CLINICAL STUDY; NAUSEA AND VOMITING; NEUTROPENIA; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT OUTCOME; TROPHOBLASTIC TUMOR; TUMOR REGRESSION;

EID: 83055194273     PISSN: 00207292     EISSN: 18793479     Source Type: Journal    
DOI: 10.1016/j.ijgo.2011.08.003     Document Type: Article

References (26)

1. K. Foulmann, J.P. Guastalla, N. Caminet, V. Trillet-Lenoir, D. Raudrant, and F. Golfier What is the best protocol of single-agent methotrexate chemotherapy in nonmetastatic or low-risk metastatic gestational trophoblastic tumors? A review of the evidence Gynecol Oncol 102 1 2006 103 110 (Pubitemid 43870235)
2. G.T. Ross, L.L. Stolbach, and R. Hertz Actinomycin D in the treatment of methotrexate-resistant trophoblastic disease in women Cancer Res 22 1962 1015 1017
3. R. Osborne, and A. Gerulath What is the best regimen for low-risk gestational trophoblastic neoplasia? A review J Reprod Med 49 8 2004 602 616 (Pubitemid 39128774)
4. A.P. Garrett, E.O. Garner, D.P. Goldstein, and R.S. Berkowitz Methotrexate infusion and folinic acid as primary therapy for nonmetastatic and low-risk metastatic gestational trophoblastic tumors. 15 years of experience J Reprod Med 47 5 2002 355 362 (Pubitemid 34553234)
5. G.T. Ross, D.P. Goldstein, R. Hertz, M.B. Lipsett, and W.D. Odell Sequential use of methotrexate and actinomycin D in the treatment of metastatic choriocarcinoma and related trophoblastic diseases in women Am J Obstet Gynecol 93 1965 223 229
6. E.S. Petrilli, L.B. Twiggs, J.A. Blessing, N.H. Teng, and S. Curry Single-dose actinomycin-D treatment for nonmetastatic gestational trophoblastic disease. A prospective phase II trial of the Gynecologic Oncology Group Cancer 60 9 1987 2173 2176 (Pubitemid 17153478)
7. L.M. Chen, E.R. Lengyel, and C. Bethan Powell Single-agent pulse dactinomycin has only modest activity for methotrexate-resistant gestational trophoblastic neoplasia Gynecol Oncol 94 1 2004 204 207 (Pubitemid 38950521)
8. H. Matsui, K. Suzuka, K. Yamazawa, N. Tanaka, A. Mitsuhashi, and K. Seki Relapse rate of patients with low-risk gestational trophoblastic tumor initially treated with single-agent chemotherapy Gynecol Oncol 96 3 2005 616 620 (Pubitemid 40255478)
9. M.E. Carney Treatment of low risk gestational trophoblastic disease Clin Obstet Gynecol 46 3 2003 579 592 (Pubitemid 37129525)
10. H. Matsui, K. Suzuka, Y. Iitsuka, K. Seki, and S. Sekiya Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors Gynecol Oncol 78 1 2000 28 31 (Pubitemid 30439474)
11. P.G. Rose, and M.S. Piver Alternating methotrexate and dactinomycin in nonmetastatic gestational trophoblastic disease J Surg Oncol 41 3 1989 148 152 (Pubitemid 19190388)
12. F.I.G.O. Oncology Committee. FIGO staging for gestational trophoblastic neoplasia 2000. FIGO Oncology Committee Int J Gynaecol Obstet 77 3 2002 285 287
13. H. Matsui, Y. Iitsuka, K. Seki, and S. Sekiya Comparison of chemotherapies with methotrexate, VP-16 and actinomycin-D in low-risk gestational trophoblastic disease. Remission rates and drug toxicities Gynecol Obstet Invest 46 1 1998 5 8 (Pubitemid 28344827)
14. L.C. Wong, Y.C. Choo, and H.K. Ma Primary oral etoposide therapy in gestational trophoblastic disease. An update Cancer 58 1 1986 14 17 (Pubitemid 16093096)
15. G.J. Rustin, E.S. Newlands, J.M. Lutz, L. Holden, K.D. Bagshawe, and J.G. Hiscox Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors J Clin Oncol 14 10 1996 2769 2773 (Pubitemid 26329663)
16. M.M. Gilani, F. Yarandi, Z. Eftekhar, and P. Hanjani Comparison of pulse methotrexate and pulse dactinomycin in the treatment of low-risk gestational trophoblastic neoplasia Aust N Z J Obstet Gynaecol 45 2 2005 161 164 (Pubitemid 40528565)
17. R.J. Osborne, V. Filiaci, J.C. Schink, R.S. Mannel, R.S. Alvarez Secord, and J.L. Kelley Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study J Clin Oncol 29 7 2011 825 831
18. F. Yarandi, Z. Eftekhar, H. Shojaei, S. Kanani, A. Sharifi, and P. Hanjani Pulse methotrexate versus pulse actinomycin D in the treatment of low-risk gestational trophoblastic neoplasia Int J Gynaecol Obstet 103 1 2008 33 37
19. E.B. Smith, J.C. Weed Jr. , L. Tyrey, and C.B. Hammond Treatment of nonmetastatic gestational trophoblastic disease: results of methotrexate alone versus methotrexate-folinic acid Am J Obstet Gynecol 144 1 1982 88 92 (Pubitemid 12054362)
20. L.C. Wong, Y.C. Choo, and H.K. Ma Methotrexate with citrovorum factor rescue in gestational trophoblastic disease Am J Obstet Gynecol 152 1 1985 59 62 (Pubitemid 15039809)
21. A.A. Lertkhachonsuk, N. Israngura, S. Wilailak, and S. Tangtrakul Actinomycin d versus methotrexate-folinic acid as the treatment of stage I, low-risk gestational trophoblastic neoplasia: a randomized controlled trial Int J Gynecol Cancer 19 5 2009 985 988
22. R.A. Abrão, J.M. de Andrade, D.G. Tiezzi, and H.R. Marana Candido dos Reis FJ, Clagnan WS. Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactinomycin and combination regimens Gynecol Oncol 108 1 2008 149 153
23. C.B. Hammond, R. Hertz, G.T. Ross, M.B. Lipsett, and W.D. Odell Primary chemotherapy for nonmetastatic gestational trophoblastic neoplasms Am J Obstet Gynecol 98 1 1967 71 78
24. E.I. Kohorn Single-agent chemotherapy for nonmetastatic gestational trophoblastic neoplasia. Perspectives for the 21st century after three decades of use J Reprod Med 36 1 1991 49 55
25. E.S. Petrilli, and C.P. Morrow Actinomycin D toxicity in the treatment of trophoblastic disease: a comparison of the five-day course to single-dose administration Gynecol Oncol 9 1 1980 18 22 (Pubitemid 10175941)
26. J.S. Kwon, L. Elit, J. Mazurka, F. Moens, and M.L. Schmuck Weekly intravenous methotrexate with folinic acid for nonmetastatic gestational trophoblastic neoplasia Gynecol Oncol 82 2 2001 367 370 (Pubitemid 32730620)